:Pembrolizumab

Janak Adhikari1, Priyadarshani Sharma1, Eddy Karnabi2

  • 1Department of Internal Medicine, Eastern Maine Medical Center, Bangor, ME, USA.

概括

作为免疫检查点抑制剂的 pembrolizumab 很少会导致心脏问题. 这一案例突出了pembrolizumab诱导的心肌炎和持续的三度心脏阻塞,强调了对心脏监测的需要.